CD8A and neoplasm: Compared to the PBS control and antigen-unloaded DC groups, the antigen peptide 619 loaded DC vaccine group exhibited a significant increase in CD8+ T lymphocytes in peripheral blood (Figures 1E, F) and enhanced infiltration of hCD45+ cells in tumor tissues (Figures 1G, H).